Building CAPA That Demonstrates the Fix Actually Worked

An effective corrective and preventive action (CAPA) program should do more than document that an issue was addressed. It should demonstrate that the root cause was identified, the appropriate corrective action was implemented, and the fix actually worked. As regulatory scrutiny increases, organizations need CAPA processes built around evidence, meaningful effectiveness checks, and investigations that can withstand inspection.

This white paper examines CAPA effectiveness in pharmaceutical, biotechnology, and medical device quality systems, including CAPA root cause analysis, effectiveness verification, investigation scope, risk-based prioritization, and CAPA metrics. It provides a practical framework for strengthening CAPA investigations, reducing recurring failures, and building a corrective and preventive action program that demonstrates results rather than simply documenting activity.

Fill out the form to receive our White Paper.